Cited by 589Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 57 of the 62 references it cites were found in a registry or an index.

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

Open access

DeUgarte, Catherine Marin, Bartolucci, Alfred A., Azziz, Ricardo·2005·Fertility and Sterility

DOI 10.1016/j.fertnstert.2004.11.070

Open this paper in CoChat — free account

Abstract

Objective To determine the prevalence of insulin resistance (IR) in a large population of patients with the polycystic ovary syndrome (PCOS).Design Prospective, case-control.Setting University medical center.Patient(s) Two hundred seventy-one PCOS patients and 260 eumenorrheic, non-hirsute, control women.Intervention(s) History and physical examination and blood sampling.Main outcome measure(s) Total T, free T, DHEAS, sex hormone-binding globulin, and fasting glucose and insulin levels; homeostatic model assessment values for IR (HOMA-IR) and percent beta-cell function (HOMA-%beta-cell).Result(s) Patients with PCOS and controls differed significantly in all parameters studied, except fasting glucose. Because the HOMA-IR and HOMA-%beta-cell values were variably associated with race, age, and body mass index, the HOMA-IR and HOMA-%beta-cell values were then adjusted for these cofounders. After adjustment, 64.4% of PCOS patients were noted to be insulin resistant, and 2.6% had beta-cell dysfunction. Compared with PCOS patients without IR (n = 96), patients with IR (n = 174) were more obese and had higher beta-cell function.Conclusion(s) In patients with PCOS, the prevalence of IR was 64% according to the HOMA-IR measurement, after adjustment. Patients with IR were more clinically affected. Although IR is a common abnormality in PCOS, it does not seem to be a universal feature.

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2004.11.070

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Self-citation
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Lévy, J., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,023
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Self-citation
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
Asunción, M., Calvo, R. M., Millán, J. L. S., Sancho, J., Ávila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,328

Flagged first, then by citations

Show all 62 references

5 of the 62 references couldn’t be matched to a known paper.

Sorted by citations

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Self-citation
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Polycystic ovary syndrome
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citation
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Self-citation
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Self-citation
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
Moran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.018 · Cited by 444
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Prevalence of polycystic ovary syndrome in women in China: a large community-based study
Li, R., Zhang, Q., Yang, D., Li, S., Lu, S., Wu, X., Wei, Z., Song, X., Wang, X., Fu, S., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det262 · Cited by 422
Abdominal adiposity and the polycystic ovary syndrome
Escobar-Morreale, H. F., & Millán, J. L. S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.003 · Cited by 386
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)
Siddiqui, S., Mateen, S., Ahmad, R., & Moin, S. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02625-7 · Cited by 404
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women
O’Kelly, A. C., Michos, E. D., SHUFELT, C. L., Vermunt, J. V., Minissian, M., Quesada, O., Smith, G. N., Rich-Edwards, J. W., Garovic, V. D., Khoudary, S. R. E., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319895 · Cited by 358
Lifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292
Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
Elkind-Hirsch, K., Marrioneaux, O., Bhushan, M., Vernor, D., & Bhushan, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0115 · Cited by 276
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Polycystic ovary syndrome current status and future perspective
Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 273
Dietary Composition in the Treatment of Polycystic Ovary Syndrome: A Systematic Review to Inform Evidence-Based Guidelines
Moran, L. J., Ko, H., Misso, M., Marsh, K., Noakes, M., Talbot, M., Frearson, M., Thondan, M., Stepto, N., & Teede, H. J. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.11.018 · Cited by 259
Cancer risk and PCOS
Dumesic, D. A., & Løbo, R. A. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.004 · Cited by 246
The Role of Chronic Inflammation in Polycystic Ovarian Syndrome—A Systematic Review and Meta-Analysis
Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E. M., Shawki, H., & Amer, S. A. K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052734 · Cited by 259
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301
Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women
Dumesic, D. A., Akopians, A. L., Madrigal, V. K., Ramirez, E., Margolis, D. J., Sarma, M. K., Thomas, A. M., Grogan, T. R., Haykal, R., Schooler, T. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2586 · Cited by 222
Should all women with PCOS be treated for insulin resistance?
Marshall, J. C., & Dunaif, A. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 224
The Role of Polycystic Ovary Syndrome in Reproductive and Metabolic Health: Overview and Approaches for Treatment
Dennett, C. C., & Simon, J. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.2.116 · Cited by 196
The Diagnosis of Polycystic Ovary Syndrome in Adolescents
Rosenfield, R. L. (2015) · PEDIATRICS · doi:10.1542/peds.2015-1430 · Cited by 201
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
Unfer, V., Facchinetti, F., Orrù, B., Giordani, B., & Nestler, J. E. (2017) · Endocrine Connections · doi:10.1530/ec-17-0243 · Cited by 220
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Treatment strategies for women with polycystic ovary syndrome
Jin, P., & Xie, Y. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1395841 · Cited by 181
Review: Role of metformin in the management of polycystic ovary syndrome
Lashen, H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380215 · Cited by 181
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome
Goodarzi, M. O., & Azziz, R. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.005 · Cited by 170
Self-citation
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., & Guan, Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0616 · Cited by 155
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152
Use of metformin in polycystic ovary syndrome
Mathur, R., Alexander, C. J., Yano, J., Trivax, B., & Azziz, R. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.09.010 · Cited by 150
Self-citation
Defining hirsutism in Chinese women: a cross-sectional study
Zhao, X., Ni, R., Li, L., Mo, Y., Huang, J., Huang, M., Azziz, R., & Yang, D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.06.040 · Cited by 145
Self-citation
First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis
Cassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Williams, G., & Norman, R. J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.77 · Cited by 141
Polycystic Ovarian Syndrome
Trikudanathan, S. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.003 · Cited by 140
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 137
Effects of lifestyle modification in polycystic ovarian syndrome
Moran, L., Brinkworth, G. D., Noakes, M., & Norman, R. J. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61182-0 · Cited by 136
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 133
Markers of insulin resistance in Polycystic ovary syndrome women: An update
Amisi, C. A. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.129 · Cited by 158
Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance
Ciaraldi, T. P., Aroda, V. R., Mudaliar, S. R. D., Chang, R. J., & Henry, R. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1492 · Cited by 130
Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene
Sachdeva, G., Gainder, S., Suri, V., Sachdeva, N. K., & Chopra, S. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_30_19 · Cited by 127
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome
Orio, F., Muscogiuri, G., Nese, C., Palomba, S., Savastano, S., Tafuri, D., Colarieti, G., La Sala, G., Colao, A., & Yildiz, B. O. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.08.026 · Cited by 126
Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles
Frolova, A. I., & Moley, K. H. (2011) · Reproduction · doi:10.1530/rep-11-0114 · Cited by 128
Systemic and ovarian inflammation in women with polycystic ovary syndrome
Zhai, Y., & Pang, Y. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103628 · Cited by 123
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility
Costello, M., Misso, M. L., Balen, A. H., Boyle, J., Devoto, L., Garad, R. M., Hart, R. J., Johnson, L., Jordan, C., Legro, R. S., et al. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy021 · Cited by 128
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome
Cascella, T., Palomba, S., Tauchmanovà, L., Manguso, F., Di Biase, S., Labella, D., Giallauria, F., Vigorito, C., Colao, A., Lombardi, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0399 · Cited by 120
Ontogeny of the ovary in polycystic ovary syndrome
Dumesic, D. A., & Richards, J. S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.011 · Cited by 118
The effects of old, new and emerging medicines on metabolic aberrations in PCOS
Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 120
Dyslipidemia in PCOS
Wild, R. A. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.002 · Cited by 117
Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) – Clinical based case control study
Malini, N. A., & George, K. R. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.12.007 · Cited by 114
The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects
Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.037 · Cited by 111
Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
Jamilian, M., Foroozanfard, F., Kavossian, E., Aghadavod, E., Shafabakhsh, R., Hoseini, A., & Asemi, Z. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.01.005 · Cited by 111
Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshreshtha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1040 · Cited by 109
Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis
Nader, S., & Diamanti-Kandarakis, E. (2007) · Human Reproduction · doi:10.1093/humrep/del407 · Cited by 109
Neuroendocrine Impairments of Polycystic Ovary Syndrome
Ruddenklau, A., & Campbell, R. E. (2019) · Endocrinology · doi:10.1210/en.2019-00428 · Cited by 116
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
Changes in the Expression of Insulin Signaling Pathway Molecules in Endometria from Polycystic Ovary Syndrome Women with or without Hyperinsulinemia
Fornes, R., Ormazabal, P., Rosas, C., Gabler, F., Vantman, D., Romero, C., & Vega, M. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00118 · Cited by 104
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway
Qiu, Z., Dong, J., Xue, C. B., Li, X., Liu, K., Liu, B., Cheng, J., & Huang, F. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111965 · Cited by 100
Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome
Nehir, A., Baştu, E., Demiral, İ., Bulut, H., Doğan, M., & Buyru, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2016.1155208 · Cited by 99
Polycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 100
Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients with Polycystic Ovary Syndrome
Izadi, A., Ebrahimi, S., Shirzai, S., Taghizadeh, S., Parizad, M., Farzadi, L., & Gargari, B. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01221 · Cited by 102
Oxidative stress and cardiovascular complications in polycystic ovarian syndrome
Hyderali, B. N., & Mala, K. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.005 · Cited by 96
Polycystic ovary syndrome and autoimmunity
Petríková, J., Lazúrová, I., & Shoenfeld, Y. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.06.008 · Cited by 94
HMGB1‐induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS
Zhang, C., Hu, J., Wang, W., Sun, Y. W., & Sun, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000605rr · Cited by 93
The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial
Abootorabi, M. S., Ayremlou, P., Behroozi-Lak, T., & Saeidlou, S. N. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1418311 · Cited by 93
Prenatal Androgenization of Female Mice Programs an Increase in Firing Activity of Gonadotropin-Releasing Hormone (GnRH) Neurons That Is Reversed by Metformin Treatment in Adulthood
Roland, A. V., & Moenter, S. M. (2010) · Endocrinology · doi:10.1210/en.2010-0823 · Cited by 95
The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
Rasmussen, C. B., & Lindenberg, S. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00140 · Cited by 90
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Farrag, M., Eldjoudi, D. A., González‐Rodríguez, M., Barreal, A. C., Ruiz‐Fernández, C., Capuozzo, M., González-Gay, M. Á., Mera, A., Lago, F., Soffar, A. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1101091 · Cited by 98
Obesity, Dietary Patterns, and Hormonal Balance Modulation: Gender-Specific Impacts
Mazza, E., Troiano, E., Ferro, Y., Lisso, F., Tosi, M., Turco, E., Pujia, R., & Montalcini, T. (2024) · Nutrients · doi:10.3390/nu16111629 · Cited by 111
Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome
Zhang, Y., Hu, M., Meng, F., Sun, X., Xu, H., Zhang, J., Cui, P., Morina, N., Li, X., Li, W., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.023 · Cited by 90
Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes
Sova, H., Unkila‐Kallio, L., Tiitinen, A. E., Hippeläinen, M., Perheentupa, A. H., Tinkanen, H., Puukka, K. S., Bloigu, R., Piltonen, T., Tapanainen, J. S., et al. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1559807 · Cited by 90
Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis
Misso, M. L., Costello, M. F., Garrubba, M., Wong, J., Hart, R., Rombauts, L., Melder, A. M., Norman, R. J., & Teede, H. J. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms036 · Cited by 81
The role of melatonin in polycystic ovary syndrome: A review
Mojaverrostami, S., Asghari, N., Khamisabadi, M., & Khoei, H. H. (2019) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v17i12.5789 · Cited by 79
Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
Al‐Jefout, M., Alnawaiseh, N. A., & Al-Qtaitat, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05717-y · Cited by 83
Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway
Zhao, H., Zhou, D., Chen, Y., Liu, D., Chu, S., & Zhang, S. (2017) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-017-0188-7 · Cited by 78
Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990
Hsu, M.-I., Liou, T., Chou, S.-Y., Chang, C.-Y., & Hsu, C.-S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.149 · Cited by 77
Racial and Ethnic Differences in Physiology and Clinical Symptoms of Polycystic Ovary Syndrome
Wang, S.-P., & Alvero, R. J. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0033-1348895 · Cited by 74
A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75
Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome
Jiang, L., Huang, J., Chen, Y.-X., Yang, Y.-B., Li, R., Li, Y., Chen, X.-L., & Yang, D.-Z. (2016) · Endocrine · doi:10.1007/s12020-016-0878-9 · Cited by 63
Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome
Ezeh, U., Pall, M., Mathur, R., & Azziz, R. (2014) · Human Reproduction · doi:10.1093/humrep/deu096 · Cited by 71
Self-citation
Effectiveness of Probiotics, Prebiotics, and Synbiotics in Managing Insulin Resistance and Hormonal Imbalance in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review of Randomized Clinical Trials
Guevara, D. M., Vidal-Cañas, S., Palacios, I., Gómez, A., Estrada, M., Gallego, J., & Liscano, Y. (2024) · Nutrients · doi:10.3390/nu16223916 · Cited by 77
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)
Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
MECHANISMS IN ENDOCRINOLOGY: Recent advances in cardiovascular aspects of polycystic ovary syndrome
Sathyapalan, T., & Atkin, S. L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0755 · Cited by 69
Ovarian failure and polycystic ovary syndrome
Petríková, J., & Lazúrová, I. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.010 · Cited by 67
Puberty and its disorders in the female
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00024-x · Cited by 67
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Effects of Controlled-Release Alpha Lipoic Acid in Lean, Nondiabetic Patients with Polycystic Ovary Syndrome
Masharani, U., Gjerde, C., Evans, J. L., Youngren, J., & Goldfine, I. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400218 · Cited by 65
Zinc and Homocysteine Levels in Polycystic Ovarian Syndrome Patients with Insulin Resistance
Güler, İ., Himmetoğlu, Ö., Turp, A. B., Erdem, A., Erdem, M., Onan, M. A., Taşkıran, Ç., Taşlıpınar, M. Y., & Güner, H. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-9941-7 · Cited by 66
Regulation of Adiponectin Secretion by Adipocytes in the Polycystic Ovary Syndrome: Role of Tumor Necrosis Factor-α
Chazenbalk, G. D., Trivax, B., Yıldız, B. O., Bertolotto, C., Mathur, R., Heneidi, S. G., & Azziz, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1158 · Cited by 66
Self-citation
Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis
Li, Y., Han, Y., & He, B. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.03.032 · Cited by 65
Polymorphisms in theSHBGGene Influence Serum SHBG Levels in Women with Polycystic Ovary Syndrome
Wickham, E. P., Ewens, K. G., Legro, R. S., Dunaif, A. E., Nestler, J. E., & Strauss, J. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1842 · Cited by 64
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking
Luque‐Ramírez, M., Mendieta-Azcona, C., Sánchez, J. M. D. R., Maties, M., & Escobar-Morreale, H. F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0725 · Cited by 61
Phenotype and genotype of polycystic ovary syndrome in Asia: Ethnic differences
Kim, J., & Choi, Y. M. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14132 · Cited by 65

Authors: DeUgarte, C. M., Bartolucci, A. A., & Azziz, R.
Affiliations: Cedars-Sinai Medical Center (US)
University of Alabama at Birmingham (US)
Corresponding author: Azziz, Ricardo
ORCID: Bartolucci, Alfred A.
Azziz, Ricardo
Venue: Fertility and Sterility
Publisher: Elsevier BV
Published: 2005-05
Volume: 83
Issue: 5
Pages: 1454-1460
ISSN: 0015-0282 (ISSN-L)
DOI: 10.1016/j.fertnstert.2004.11.070
OpenAlex: W2117559317
Cited by: 589
References: 62
Citations by year: 2026: 14 · 2025: 23 · 2024: 24 · 2023: 30 · 2022: 41 · 2021: 32 · 2020: 33 · 2019: 33 · 2018: 23 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 33 · 2013: 48 · 2012: 21
FWCI: 23.24
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 6235 d)
Locations: Fertility and Sterility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, insulin resistance, HOMA-IR, beta-cell function, prevalence, obesity, sex hormones, insulin secretion
MeSH terms: Adult, Female, Homeostasis, Humans, Insulin Resistance, Middle Aged, Polycystic Ovary Syndrome, Prospective Studies, Prevalence, Chi-Square Distribution, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks